Patent ID: 8741326

Claim:
A composition comprising: a first mixture comprising a first component of a first two-component gel system and a first component of a second two-component gel system, wherein the first component of the first two component gel system is one of an alginate-collagen, an alginate-laminin, an alginate-elastin, an alginate-collagen-laminin, an alginate-hyaluronic acid, an alginate and a self-assembled peptide, and wherein the first component of the second two-component gel system is one of fibrinogen, a fibrinogen conjugate, and sodium hyaluronate, and a second mixture comprising a second component of the first two-component gel system and a second component of the second two-component gel system, wherein the second component of the first two-component gel system is one of sodium chloride, calcium chloride, barium chloride, strontium chloride and sucrose, and wherein the second component of the second two-component gel system is different than the second component of the first two-component gel system, and is one of thrombin and sucrose, and wherein upon separately injecting the first mixture and the second mixture into a post-myocardial infarction area of a heart, the first component and the second component of the first two-component gel system mix to form a first gel and the first component and the second component of the second two-component gel system mix to form a second gel, and wherein the first gel has a different characteristic than the second gel.